Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions
Biodesix to Participate in Upcoming Investor Conferences
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $22
Biodesix, Inc. Q1 2026 Earnings Call Summary
Biodesix (BDSX) Q1 2026 Earnings Transcript
Biodesix Q1 Earnings Call Highlights
Biodesix BDSX Q2 2025 Earnings Call Transcript
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance
Biodesix Announces First Quarter 2026 Results and Highlights
Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript
Biodesix Q1 2026 Earnings Call: Complete Transcript
Biodesix Raises FY2026 Sales Guidance from $106.000M-$112.000M to $108.000M-$114.000M vs $108.680M Est
Biodesix Q1 EPS $(0.81) Beats $(1.12) Estimate, Sales $25.555M Beat $23.178M Estimate
How Recent Shifts Are Reframing The Biodesix (BDSX) Investment Story
Biodesix Recognized as a Top Workplace for Third Consecutive Year
Biodesix To Present Seven Abstracts At AACR Annual Meeting From April 17 To 22 Demonstrating Biodesix's Capabilities In Blood- And Tissue-Based Testing And Monitoring
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.